ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,390.41
-0.31%
Dow Jones
39,872.99
0.17%
Gold vs US Dollar
2,416.78
-0.19%
Brent Oil
81.645
-0.97%
Bitcoin
69,938.38
-0.29%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV
  6. Hls Therapeutics (HLS)

  7. Hls Therapeutics (HLS) News

Hls Therapeutics (HLS)

Hls Therapeutics
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:HLS
DateTimeSourceHeadlineSymbolCompany
19/02/201911:30PR Newswire (Canada)HLS Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare ConferenceTSXV:HLSHls Therapeutics
06/02/201911:30PR Newswire (Canada)HLS Therapeutics Announces Graduation to the Toronto Stock ExchangeTSXV:HLSHls Therapeutics
29/01/201911:30PR Newswire (Canada)HLS Therapeutics Receives Conditional Approval to Graduate to the Toronto Stock ExchangeTSXV:HLSHls Therapeutics
15/11/201811:30PR Newswire (Canada)HLS Therapeutics Announces Q3 2018 Financial ResultsTSXV:HLSHls Therapeutics
12/11/201811:30PR Newswire (Canada)HLS Therapeutics Announces that Amarin's Vascepa ® (icosapent ethyl) Demonstrates 26% Reduction in Key Secondary Composite E...TSXV:HLSHls Therapeutics
01/11/201810:30PR Newswire (Canada)HLS Therapeutics to Host 2018 Third Quarter Results Conference CallTSXV:HLSHls Therapeutics
24/09/201810:30PR Newswire (Canada)HLS Therapeutics Announces that Amarin's REDUCE-IT™ Cardiovascular Outcomes Study of Vascepa® (icosapent ethyl) Capsules M...TSXV:HLSHls Therapeutics
06/09/201811:30PR Newswire (Canada)HLS Therapeutics Appoints Tim Hendrickson as CFOTSXV:HLSHls Therapeutics
22/08/201823:08PR Newswire (Canada)HLS Therapeutics Announces Grant of Stock OptionsTSXV:HLSHls Therapeutics
15/08/201811:30PR Newswire (Canada)HLS Therapeutics Announces Q2 2018 Financial ResultsTSXV:HLSHls Therapeutics
30/07/201811:30PR Newswire (Canada)HLS Therapeutics to Host 2018 Second Quarter Results Conference CallTSXV:HLSHls Therapeutics
25/06/201811:30PR Newswire (Canada)HLS Therapeutics Reports Annual Meeting ResultsTSXV:HLSHls Therapeutics
15/06/201811:30PR Newswire (Canada)HLS Therapeutics to Host Annual Shareholder MeetingTSXV:HLSHls Therapeutics
30/05/201811:30PR Newswire (Canada)HLS Therapeutics Enters into Automatic Share Purchase PlanTSXV:HLSHls Therapeutics
16/05/201811:30PR Newswire (Canada)HLS Therapeutics Announces Q1 2018 Financial ResultsTSXV:HLSHls Therapeutics
09/05/201822:00PR Newswire (Canada)HLS Therapeutics Announces Normal Course Issuer BidTSXV:HLSHls Therapeutics
09/05/201811:30PR Newswire (Canada)HLS Therapeutics to Host 2018 First Quarter Results Conference CallTSXV:HLSHls Therapeutics
07/05/201811:30PR Newswire (Canada)HLS Appoints Ryan Lennox as General CounselTSXV:HLSHls Therapeutics
26/04/201811:30PR Newswire (Canada)HLS Therapeutics Announces Partial Redemption of Preferred SharesTSXV:HLSHls Therapeutics
20/04/201811:30PR Newswire (Canada)HLS to Present at the 2018 Bloom Burton & Co. Healthcare Investor ConferenceTSXV:HLSHls Therapeutics
29/03/201811:30PR Newswire (Canada)HLS Therapeutics Announces Fiscal 2017 Financial ResultsTSXV:HLSHls Therapeutics
19/03/201820:00PR Newswire (Canada)HLS Therapeutics to Host 2017 Fourth Quarter and Year End Results Conference CallTSXV:HLSHls Therapeutics
16/03/201815:00PR Newswire (Canada)HLS Therapeutics Inc. Opens the MarketTSXV:HLSHls Therapeutics
13/03/201820:15PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - GPLY; HLSTSXV:HLSHls Therapeutics
13/03/201820:13PR Newswire (Canada)IIROC Trading Resumption - GPLY; HLSTSXV:HLSHls Therapeutics
12/03/201822:01PR Newswire (Canada)HLS Therapeutics Completes Merger with Automodular CorporationTSXV:HLSHls Therapeutics
06/10/201021:19Marketwired CanadaTSX Venture Exchange Daily Bulletins for October 6, 2010TSXV:HLSHls Therapeutics
14/05/201021:50Marketwired CanadaTSX Venture Exchange Daily Bulletins for May 14, 2010TSXV:HLSHls Therapeutics
10/05/201014:44Marketwired CanadaSouthern Hemisphere Mining Limited: New Jorc Resource and Progress Update Los Pumas Manganese Project, ChileTSXV:HLSHls Therapeutics
06/05/201012:02Marketwired CanadaEurocontrol Technics Inc.: Athlone Global Security Investee Company Awarded Singapore Israel Industrial Research and DevelopmentTSXV:HLSHls Therapeutics
 Showing the most relevant articles for your search:TSXV:HLS

Your Recent History

LSE
POLX
Polarean Imaging
LSE
POS
Plexus
LSE
ZED
Zenova
LSE
PHE
Powerhouse Energy
LSE
AAZ
Anglo Asian Mining
LSE
LLOY
Lloyds Banking
LSE
SCLP
Scancell
LSE
GGP
Greatland Gold
LSE
PHNX
Phoenix
LSE
CYAN
Cyanconnode
LSE
TERN
Tern
LSE
RGL
Regional Reit
LSE
GKP
Gulf Keystone Petroleum
LSE
SCE
Surface Transforms
LSE
KEFI
Kefi Gold And Copper
LSE
RKH
Rockhopper Exploration
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved